Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Comparative Stability Studies of Different Infliximab and Biosimilar CT-P13 Clinical Solutions by Combined Use of Physicochemical Analytical Techniques and Enzyme-Linked Immunosorbent Assay (ELISA).

Hermosilla J, Sánchez-Martín R, Pérez-Robles R, Salmerón-García A, Casares S, Cabeza J, Cuadros-Rodríguez L, Navas N.

BioDrugs. 2019 Apr;33(2):193-205. doi: 10.1007/s40259-019-00342-9.

PMID:
30875076
2.

Development and validation of a (RP)UHPLC-UV-(HESI/Orbitrap)MS method for the identification and quantification of mixtures of intact therapeutical monoclonal antibodies using a monolithic column.

Pérez-Robles R, Cuadros-Rodríguez L, Salmerón-García A, Navas N.

J Pharm Biomed Anal. 2018 Sep 10;159:437-448. doi: 10.1016/j.jpba.2018.07.013. Epub 2018 Jul 17.

PMID:
30071467
3.

Extravasation accidents with liposomal/liposomal pegylated anthracyclines treated with dexrazoxane: an overview and outcomes.

Caballero Romero Á, Delgado Ureña MT, Salmerón García A, Megías Fernández MT, Librada Porriño-Bustamante M, Cabeza Barrera J.

Anticancer Drugs. 2018 Oct;29(9):821-826. doi: 10.1097/CAD.0000000000000672. Review.

PMID:
30036190
4.

Study of aggregation in therapeutic monoclonal antibodies subjected to stress and long-term stability tests by analyzing size exclusion liquid chromatographic profiles.

Hernández-Jiménez J, Martínez-Ortega A, Salmerón-García A, Cabeza J, Prados JC, Ortíz R, Navas N.

Int J Biol Macromol. 2018 Oct 15;118(Pt A):511-524. doi: 10.1016/j.ijbiomac.2018.06.105. Epub 2018 Jun 23.

PMID:
29944945
5.

Validated reverse phase HPLC diode array method for the quantification of intact bevacizumab, infliximab and trastuzumab for long-term stability study.

Martínez-Ortega A, Herrera A, Salmerón-García A, Cabeza J, Cuadros-Rodríguez L, Navas N.

Int J Biol Macromol. 2018 Sep;116:993-1003. doi: 10.1016/j.ijbiomac.2018.05.142. Epub 2018 May 21.

PMID:
29792967
6.

Development and use of specific ELISA methods for quantifying the biological activity of bevacizumab, cetuximab and trastuzumab in stability studies.

Suárez I, Salmerón-García A, Cabeza J, Capitán-Vallvey LF, Navas N.

J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Oct 1;1032:155-164. doi: 10.1016/j.jchromb.2016.05.045. Epub 2016 May 27.

PMID:
27296731
7.

Study and ICH validation of a reverse-phase liquid chromatographic method for the quantification of the intact monoclonal antibody cetuximab.

Martínez-Ortega A, Herrera A, Salmerón-García A, Cabeza J, Cuadros-Rodríguez L, Navas N.

J Pharm Anal. 2016 Apr;6(2):117-124. doi: 10.1016/j.jpha.2015.11.007. Epub 2015 Nov 27.

8.

The Effects of Light-Accelerated Degradation on the Aggregation of Marketed Therapeutic Monoclonal Antibodies Evaluated by Size-Exclusion Chromatography With Diode Array Detection.

Hernández-Jiménez J, Salmerón-García A, Cabeza J, Vélez C, Capitán-Vallvey LF, Navas N.

J Pharm Sci. 2016 Apr;105(4):1405-18. doi: 10.1016/j.xphs.2016.01.012. Epub 2016 Mar 4.

PMID:
26952878
9.

Medication reconciliation at admission and discharge: an analysis of prevalence and associated risk factors.

Belda-Rustarazo S, Cantero-Hinojosa J, Salmeron-García A, González-García L, Cabeza-Barrera J, Galvez J.

Int J Clin Pract. 2015 Nov;69(11):1268-74. doi: 10.1111/ijcp.12701. Epub 2015 Jul 22.

PMID:
26202091
10.

Medication reconciliation at admission to surgical departments.

González-García L, Salmerón-García A, García-Lirola M, Moya-Roldán S, Belda-Rustarazo S, Cabeza-Barrera J.

J Eval Clin Pract. 2016 Feb;22(1):20-25. doi: 10.1111/jep.12403. Epub 2015 Jun 17.

PMID:
26083630
11.

Cluster-based comparison of the peptide mass fingerprint obtained by MALDI-TOF mass spectrometry. A case study: long-term stability of rituximab.

Villacorta PJ, Salmerón-García A, Pelta DA, Cabeza J, Lario A, Navas N.

Analyst. 2015 Mar 7;140(5):1717-30. doi: 10.1039/c4an01806k. Epub 2015 Jan 22.

PMID:
25612326
12.

Stability of daptomycin 5 mg/mL and heparin sodium 100 units/mL combined in lactated Ringer's injection and stored in polypropylene syringes at 4 and -20°C.

Ortega R, Salmerón-García A, Cabeza J, Capitán-Vallvey LF, Navas N.

Am J Health Syst Pharm. 2014 Jun 1;71(11):956-9. doi: 10.2146/ajhp130481.

PMID:
24831000
13.

Quantification of an intact monoclonal antibody, rituximab, by (RP)HPLC/DAD in compliance with ICH guidelines.

Navas N, Herrera A, Martínez-Ortega A, Salmerón-García A, Cabeza J, Cuadros-Rodríguez L.

Anal Bioanal Chem. 2013 Nov;405(29):9351-63. doi: 10.1007/s00216-013-7368-1.

PMID:
24121431
14.

Topical endotracheal mitomycin C as a complementary treatment for endoscopic treatment of recurrent laryngotracheal stenosis.

Cortés de Miguel S, Cabeza Barrera J, Gallardo Medina M, Cassini Gómez de Cádiz LF, Salmerón-García A, Rodríguez Lucas F.

Farm Hosp. 2011 Jan-Feb;35(1):32-5. doi: 10.1016/j.farma.2010.04.002. Epub 2010 Dec 16. Review. English, Spanish.

PMID:
20663704
15.

Detection of adverse drug reactions through the minimum basic data set.

Salmerón-García A, Cabeza Barrera J, Vergara Pavón MJ, Román Márquez E, Cortés de Miguel S, Vallejo-Rodríguez I, Raya García S, Casado Fernández E.

Pharm World Sci. 2010 Jun;32(3):322-8. doi: 10.1007/s11096-010-9372-2. Epub 2010 Mar 6.

PMID:
20213432
16.

Determination of tramadol, metamizole, ropivacaine, and bupivacaine in analgesic mixture samples by HPLC with DAD detection.

Salmerón-García A, Navas N, Martín A, Román E, Cabeza J, Capitán-Vallvey LF.

J Chromatogr Sci. 2009 Mar;47(3):231-7.

PMID:
19298711
17.

[Inappropriate commercial presentation of selected drugs and associated overcost].

Toledano Mayoral G, Salmerón García A, Román Márquez E, Cabeza Barrera J.

Farm Hosp. 2006 May-Jun;30(3):195-6. Spanish. No abstract available.

18.

[Quality of clinical trials provided in GINF].

Salmerón-García A, Toledano Mayoral G, Román Márquez E, Cabeza Barrera J, Damas Fernández-Fígares M.

Farm Hosp. 2005 Sep-Oct;29(5):346-7. Spanish. No abstract available.

Supplemental Content

Loading ...
Support Center